Coherus biosciences Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Coherus biosciences Contact Number

Contact Us Coherus BioSciences

5 hours ago Coherus.com Show details

Contact Us. Coherus is dedicated to improving lives by expanding access to biologics. We value your feedback and encourage you to contact us with questions or requests for information. For medical or product inquiries, please click here.

Category: Contact SupportShow more

Contact Us Coherus BioSciences, Inc.

1 hours ago Investors.coherus.com Show details

Transfer Agent. EQ Shareowner Services P.O. Box 64874 St. Paul, MN 55164-0856 - Or - EQ Shareowner Services 1110 Centre Point Curve, Suite 101 Mendota Heights, MN 55120-4100

Category: Contact SupportShow more

Contact Us UDENYCA® (pegfilgrastimcbqv)‎

5 hours ago Udenyca.com Show details

800-794-5434Phone Number. Email Address. Subject * Inquiry/Message * Please do not include Patient Health Information when sending requests. Our Contact Information Coherus BioSciences 333 Twin Dolphin Drive Suite 600 Redwood City, CA 94065 Phone: 1-800-794-5434. To report SUSPECTED ADVERSE

Category: Contact SupportShow more

Medical & Scientific Inquiries Coherus BioSciences

6 hours ago Coherus.com Show details

800-483-3692If you are a U.S. healthcare professional and would like to submit a medical or scientific inquiry, please fill out the form below. You will be contacted by a Coherus Medical Information representative. Any adverse events or product complaints should be reported immediately to Coherus BioSciences Medical Information at 1-800-483-3692.

Category: Contact NumberShow more

Coherus BioSciences Choice Without Compromise

4 hours ago Coherus.com Show details

Coherus BioSciences Mourns the Passing of Board Member Alan C. Mendelson “Alan was truly a titan of the biotech industry, without peer in his discipline, and this is such tremendous loss on so many levels for so many people. His contributions and impact on the industry through its genesis and evolution are difficult to overstate.

Category: Contact NumberShow more

Coherus Biosciences, Inc. Company Profile Redwood City

7 hours ago Dnb.com Show details

Coherus Biosciences, Inc. is located in Redwood City, CA, United States and is part of the Scientific Research & Development Services Industry. Coherus Biosciences, Inc. has 232 total employees across all of its locations and generates $475.82 million in sales (USD). There are 2 companies in the Coherus Biosciences, Inc. corporate family.

Category: Contact NumberShow more

Coherus Biosciences Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Show details

(650) 649-3530Company Type For Profit. Phone Number (650) 649-3530. Coherus Biosciences is a biopharmaceutical company that engages in the development, manufacture, and commercialization of biologic therapeutics. The company develops biologic medicines primarily for …

Category: Contact NumberShow more

Coherus BioSciences Corporate Headquarters, Office

6 hours ago Craft.co Show details

All Coherus BioSciences Locations. Redwood City (HQ), CA. United States. 333 Twin Dolphin Dr #600. Camarillo, CA. United States. 1000 Avenida Acaso. Report incorrect company information. Location of similar companies.

Category: Contact NumberShow more

Coherus BioSciences Information Coherus BioSciences Profile

7 hours ago Rocketreach.co Show details

Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010, Coherus is a late-stage biologics platform company focused on the global biosimilar market.

Category: Contact NumberShow more

Coherus BioSciences Email Format coherus.com Emails

2 hours ago Rocketreach.co Show details

Coherus BioSciences uses 1 email formats: 1. first_initial [email protected]coherus.com (100.0%). Enter a name to find & verify an email >>> we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering. With the shear number

Category: Contact NumberShow more

Coherus COMPLETESupport for UDENYCA® (pegfilgrastimcbqv

3 hours ago Coheruscomplete.com Show details

844-483-3692If you have not elected to receive payments electronically for other payers, please contact Coherus COMPLETE™ at 1-844-483-3692 for additional information. Virtual Debit Card. Once the claim is approved, you will receive a Virtual Debit Card (VDC) Confirmation Fax. This fax will include: 16-digit VDC number.

Category: Support NumberShow more

CoPay Assistance Program Coherus COMPLETE

8 hours ago Coheruscomplete.com Show details

844-483-3692The patient MUST contact Coherus COMPLETE ™ at 1-844-4-UDENYCA (1-844-483-3692) to • 16-digit VDC number • 3-digit security code • Associated zip code of 27560 insurance to Coherus BioSciences, Inc., its affiliates, its program administrator, and …

Category: Contact NumberShow more

About Coherus BioSciences

8 hours ago Coherus.com Show details

Coherus is focused on expanding patient access to important, cost-effective medicines and delivering significant savings to the U.S. healthcare system. Every member of the Coherus team is dedicated, motivated, and passionate about expanding patient access to lifesaving therapeutics. Our colleagues are experts in analytical and process sciences

Category: Contact NumberShow more

SEC Filing Coherus BioSciences, Inc.

5 hours ago Investors.coherus.com Show details

Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: US-DOCS\114598954.4. COHERUS BIOSCIENCES, INC. …

Category: Contact NumberShow more

A Patient’s Guide to Accessing Coherus COMPLETE

7 hours ago Coheruscomplete.com Show details

toll-free number • It is important to take this call to verify your insurance information, you can call your Specialty Pharmacy at the contact telephone number to complete the request: Coherus BioSciences™ reserves the right, at its sole discretion, to revise, …

Category: Contact NumberShow more

Darlene Horton's email & phone Coherus BioSciences's

1 hours ago Rocketreach.co Show details

We had no where to begin. Scouring the web at all hours of the night wasn't gonna cut it. RocketReach has given us a great place to start. Our workflow has solid direction now - we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering.

Category: Phone NumberShow more

Careers Coherus BioSciences

8 hours ago Coherus.com Show details

Coherus offers a total rewards program which includes competitive base salary, target bonus based on performance, stock options, healthcare coverage, and additional perks and benefits. Coherus pays 90% of premiums for medical, dental, and vision coverage for our employees.

Category: Contact NumberShow more

Balance Sheet Coherus BioSciences, Inc.

5 hours ago Investors.coherus.com Show details

Number of Products in Phase I Number of Products in Phase I represents the number of products/compounds the company has in Phase 1 clinical trials. Phase 1 clinical trials investigate the safety and proper dose ranges of a product candidate in a small number

Category: Contact NumberShow more

InteKrin Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Show details

650-941-5501Contact Email [email protected] Phone Number 650-941-5501 InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.

Category: Contact NumberShow more

Junshi Biosciences and Coherus Announce U.S. FDA

3 hours ago Finance.yahoo.com Show details

(650) 395-0152Coherus Contact Information: IR Contact: McDavid Stilwell Coherus BioSciences, Inc. [email protected]coherus.com +1 (650) 395-0152. Media Contact: Sheryl Seapy Real Chemistry [email protected] +1

Category: Contact NumberShow more

Steve Spodick Email, Phone Executive Director

2 hours ago Adapt.io Show details

Find Steve Spodick's accurate email address and contact/phone number in Adapt.io. Currently working as Executive Director, Regional Sales Oncology, Northeast at Coherus BioSciences

Category: Phone NumberShow more

Coherus BioSciences Reports First Quarter 2021 Financial

9 hours ago Investors.coherus.com Show details

This guidance is subject to a number of risks and uncertainties. Coherus BioSciences, Inc. Reconciliation of GAAP Net (Loss) Income to Non-GAAP Net Income Contact McDavid Stilwell Chief Financial Officer Coherus BioSciences, Inc. [email protected]coherus

Category: Contact NumberShow more

Coherus BioSciences Biocom California

Just Now Biocom.org Show details

Founded in 2010, Coherus Biosciences is a biosimilar company that develops and commercializes therapeutics for regulated markets. The company is based in Redwood City, CA.

Category: Contact NumberShow more

AM PM Enrollment Form Coherus COMPLETE

2 hours ago Coheruscomplete.com Show details

844-483-3692Call 1-844-4-UDENYCA (1-844-483-3692) Monday through Friday • 8 am to 8 pm et Fax 1-877-226-6370 www.CoherusCOMPLETE.com Patient Assistance Program Under this program, Coherus BioSciences agrees to ship product to the provider for patients who qualify for

Category: Contact NumberShow more

Coherus BioSciences : Announces Upcoming Medical

2 hours ago Marketscreener.com Show details

(650) 395-0152Coherus BioSciences Contact Information: IR Contact: McDavid Stilwell Coherus BioSciences, Inc. [email protected]coherus.com +1 (650) 395-0152. Media Contact: Sheryl Seapy Real Chemistry [email protected] +1 (949) 903-4750

Category: Contact NumberShow more

Company Coherus Biosciences News, Employees and Funding

4 hours ago Topionetworks.com Show details

Coherus Biosciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010, Coherus is the leading biologics platform company developing biosimilar therapeutics for global markets. As a pure play company in the biosimilar space, …

Category: Contact NumberShow more

Coherus BioSciences Reports Second Quarter 2021 Financial

2 hours ago Investors.coherus.com Show details

* 2021 payments includes license fees of $145.0 million pursuant to the collaboration agreement with Junshi Biosciences paid in the first quarter which was partially offset by a $9.0 million credit related to the fair value of the discount for lack of marketability on the common shares purchased under the stock purchase agreement with Junshi Biosciences in the second quarter.

Category: Contact NumberShow more

Coherus BioSciences Number of Employees 20132021 CHRS

6 hours ago Macrotrends.net Show details

Coherus BioSciences number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics.

Category: Contact NumberShow more

Coherus Biosciences Funding, Financials, Valuation

8 hours ago Crunchbase.com Show details

Coherus Biosciences has raised a total of $377.5M in funding over 10 rounds. Their latest funding was raised on Feb 2, 2021 from a Post-IPO Equity round. Coherus Biosciences is registered under the ticker NASDAQ:CHRS . Their stock opened with $14.00 in its Nov 7, 2014 IPO. Coherus Biosciences is funded by 18 investors.

Category: Contact NumberShow more

Dennis M. Lanfear Net Worth, Biography & Insider Trading

7 hours ago Insidertrades.com Show details

(650) 649-3530The corporate mailing address for Mr. Lanfear and other Coherus BioSciences executives is 333 TWIN DOLPHIN DRIVE SUITE 600, REDWOOD CITY CA, 94065. Coherus BioSciences can also be reached via phone at (650) 649-3530 and via email at [email protected]

Category: Contact NumberShow more

Junshi Biosciences and Coherus Announce Completion of

2 hours ago Finance.yahoo.com Show details

(650) 395-0152Coherus Contact Information: IR Contact: McDavid Stilwell Coherus BioSciences, Inc. [email protected]coherus.com +1 (650) 395-0152. Media Contact: Sheryl Seapy Real Chemistry [email protected] +1

Category: Contact NumberShow more

Coherus BioSciences, inc (CHRS) Q2 2021 Earnings Call

9 hours ago Fool.com Show details

Coherus BioSciences, inc (CHRS) Q2 2021 Earnings Call Transcript CHRS earnings call for the period ending June 30, 2021.

Category: Contact NumberShow more

Stephen C. Glover CoFounder, CEO, President and

Just Now Crunchbase.com Show details

Additionally, Stephen C. Glover has had 2 past jobs including Chairman Commercial Advisory Board at Coherus Biosciences. Variant Pharmaceuticals Co-Founder, CEO, President and Director Mar 15, 2014 ZyVersa Therapeutics Co-Founder, Chairman & Chief Executive Officer Mar 2014

Category: Contact NumberShow more

Coherus COMPLETE™ Product Replacement Program Program

5 hours ago Coheruscomplete.com Show details

844-483-3692Call 1-844-4-UDENYCA (1-844-483-3692) Monday through Friday • 8 am to 8 pm et Fax 1-877-226-6370 www.CoherusCOMPLETE.com 1 Program Description • This program allows physician offices or hospital outpatient departments to receive UDENYCA® (pegfilgrastim-cbqv) replacement product if …

Category: Contact NumberShow more

What Are Biosimilars? UDENYCA® (pegfilgrastimcbqv)‎

6 hours ago Udenyca.com Show details

Coherus BioSciences was established in 2010 with the mission to improve patient access to high-quality biologics for life-altering diseases by leveraging the biosimilar regulatory pathway. contact Coherus BioSciences at 1-800-4-UDENYCA to reduce the potential number and length of hospitalizations for cancer patients undergoing various

Category: Contact NumberShow more

Coherus BioSciences : Positive Interim Results of CHOICE

8 hours ago Marketscreener.com Show details

(650) 395-0152Coherus Contact Information: IR Contact: McDavid Stilwell Coherus BioSciences, Inc. [email protected]coherus.com +1 (650) 395-0152. Media Contact: Sheryl Seapy Real Chemistry [email protected] +1 (949) 903-4750. Junshi Biosciences Contact Information IR Team: Junshi Biosciences [email protected] + 86 021-2250 0300. Solebury Trout Bob Ai bai

Category: Contact NumberShow more

Coherus Stock Price CHRS Macroaxis

8 hours ago Macroaxis.com Show details

Coherus Bio is selling at 17.52 as of the 12th of October 2021; that is -1.24% down since the beginning of the trading day. The stock's lowest day price was 17.23. Get the latest Coherus Bio detailed stock quotes, stock trade data, stock price info, and performance analysis, including Coherus Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

📉 COHERUS BIOSCIENCES INC Share Price CHRS Share Price

4 hours ago Stockopedia.com Show details

Shares in Coherus BioSciences Inc are currently trading at $17.27 and the price has moved by -23.24% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Coherus BioSciences Inc price has moved by -34.54% over the past year.

Category: Contact NumberShow more

Coherus BioSciences : Mourns the Passing of Board Member

2 hours ago Marketscreener.com Show details

About Coherus BioSciences Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com. Coherus Contact Information:

Category: Contact NumberShow more

Positive Interim Results of CHOICE01 Study Evaluating

Just Now Finance.yahoo.com Show details

(650) 395-0152Coherus Contact Information: IR Contact: McDavid Stilwell Coherus BioSciences, Inc. [email protected]coherus.com +1 (650) 395-0152. Media Contact: Sheryl Seapy Real Chemistry [email protected] +1

Category: Contact NumberShow more

Coherus BioSciences Reports Second Quarter 2021 Financial

8 hours ago Finance.yahoo.com Show details

– Second quarter 2021 UDENYCA® net sales of $88 million – – Conference call today at 5:00 p.m. ET – REDWOOD CITY, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences

1. Author: Coherus Biosciences, Inc.

Category: Contact NumberShow more

SEC FORM D

4 hours ago Sec.gov Show details

(650) 649-3530Coherus BioSciences, Inc. Street Address 1 Street Address 2; C/O DENNIS M. LANFEAR: 201 REDWOOD SHORES PARKWAY, SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; REDWOOD CITY: CALIFORNIA: 94065 (650) 649-3530

Category: Contact NumberShow more

Coherus Announces BLA Filing for Lucentis® (ranibizumab

8 hours ago Marketscreener.com Show details

FDA has set a target action date of August 2, 2022 for the CHS-201 BLA; REDWOOD CITY, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced the United States Food and Drug Administration (FDA) has accepted for review the 351(k) Biologics License Application (BLA) for CHS-201, a biosimilar candidate of reference …

Category: Contact NumberShow more

Coherus BioSciences : Announces BLA Filing for Lucentis

6 hours ago Marketscreener.com Show details

FDA has set a target action date of August 2, 2022 for the CHS-201 BLA; REDWOOD CITY, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced the United States Food and Drug Administration (FDA) has accepted for review the 351(k) Biologics License Application (BLA) for CHS-201, a biosimilar candidate of reference …

Category: Contact NumberShow more

FORM D SEC

4 hours ago Sec.gov Show details

(650) 649-3530Coherus BioSciences, Inc. Street Address 1 Street Address 2; C/O DENNIS M. LANFEAR: 201 REDWOOD SHORES PARKWAY, SUITE 200: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; REDWOOD CITY: CALIFORNIA: 94065 (650) 649-3530

Category: Contact NumberShow more

James I. Healy Net Worth, Biography & Insider Trading History

4 hours ago Insidertrades.com Show details

(650) 649-3530The corporate mailing address for Dr. Healy and other Coherus BioSciences executives is 333 TWIN DOLPHIN DRIVE SUITE 600, REDWOOD CITY CA, 94065. Coherus BioSciences can also be reached via phone at (650) 649-3530 and via email at [email protected]

Category: Contact NumberShow more

Analysts Estimate Coherus BioSciences (CHRS) to Report a

8 hours ago Finance.yahoo.com Show details

For the last reported quarter, it was expected that Coherus BioSciences would post earnings of $0.25 per share when it actually produced earnings of $0.12, delivering a surprise of …

Category: Contact NumberShow more

Working at Coherus Biosciences: Employee Reviews Indeed.com

4 hours ago Indeed.com Show details

Having been at Coherus for 2.5 years, I have been fortunate to be a part of an extremely rewarding journey! You work cross functionally with many teams, and have a lot of exposure to the projects that are taking place. Even though we have grown quite a bit, the teams remain very close and have a lot of communication and collaboration.

Rating: 3.3/5(8)

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is Coherus Biosciences?

Coherus BioSciences is a leading biosimilar company that develops and commercializes high-quality therapeutics for major regulated markets.

Where is Coherus Biosciences in Camarillo, CA?

Coherus, founded in 2010 by biotechnology industry veterans, is headquartered in the heart of California’s Silicon Valley and has its scientific labs in Camarillo, California. Coherus is dedicated to improving lives with the potential to reduce costs and expand patient access.

When does Coherus Biosciences report second quarter results?

Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in September. Coherus BioSciences Reports Corporate Highlights and Second Quarter 2019 Financial Results. At Coherus, we believe that biosimilars have the potential to help offset the increasing cost of healthcare.

Are there any new drugs that Coherus is developing?

Toripalimab is an investigational new drug currently being evaluated by the FDA for commercial distribution in the United States. Our foundational first step in immuno-oncology begins with Junshi Biosciences’ anti-PD-1 antibody.

Popular Brands

Costco
Cisco
Ccu
Cae